Multi-modal image analysis for large-scale cancer tissue studies within IMMUcan

IMMUcan 中的多模态图像分析用于大规模癌症组织研究

阅读:11
作者:Nils Eling ,Julien Dorier ,Sylvie Rusakiewicz ,Robin Liechti ,Preethi Devanand ,Michelle Daniel ,Jonas Windhager ,Bruno Palau Fernandez ,Sophie Déglise ,Lucie Despland ,Abdelkader Benyagoub ,Marcin Możejko ,Dawid Uchal ,Ewa Szczurek ,Alexander Loboda ,Daaf Sandkuijl ,Nikesh Parsotam ,Henoch S Hong ,Marie Morfouace ,Nicolas Guex ,George Coukos ,Bernd Bodenmiller ,Stephanie Tissot ,Daniel Schulz

Abstract

In cancer research, multiplexed imaging allows detailed characterization of the tumor microenvironment (TME) and its link to patient prognosis. The integrated immunoprofiling of large adaptive cancer patient cohorts (IMMUcan) consortium collects multi-modal imaging data from thousands of patients with cancer to perform broad molecular and cellular spatial profiling. Here, we describe and compare two workflows for multiplexed immunofluorescence (mIF) and imaging mass cytometry (IMC) developed within IMMUcan to enable the generation of standardized data for cancer tissue analysis. The IFQuant software supports web-based, user-friendly, and reproducible analysis of mIF data. High sample throughput for IMC is achieved by optimizing experimental protocols, developing a robotic arm for automated slide loading, and classification-based cell typing. Using our manually labeled single-cell data, we show that tree-based methods outperform other cell-phenotyping tools. These pipelines form the basis for multiplexed image analysis within IMMUcan, and we summarize our learnings from 5 years of development and optimization.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。